ProCare welcomes Pharmac’s announcement to improve access to some asthma inhalers and long-acting contraceptives from 1 August. The changes represent a significant step forward in supporting equitable, patient-centred primary care across Aotearoa.

The changes will impact funded treatments, including:

• combination inhalers branded as Symbicort Turbuhaler, DuoResp Spiromax, and Vannair
• long-acting contraceptives branded as Mirena, Jaydess, and Jadelle.

From next month, patients will be able to receive a three-month supply of the inhalers at once, and these, along with the long-acting contraceptives will be stocked in general practices for the first time.

This change will reduce the need for people to visit their pharmacy to pick up their prescription and mean people can learn how to use their inhalers and collect them at the same time, rather than returning for a follow-up.

Bindi Norwell, Chief Executive at ProCare sees the decision as a win for increasing accessibility to treatment and for efficiency of work in primary care.

“Reducing barriers to get timely access to treatment, especially for people managing chronic conditions like asthma means our health care professionals can help them get better health outcomes sooner.

“However, we do want to sound a warning to members of the public around the IUD insertions. As per Medical Council requirements, GPs are required to ensure that patients are informed and have time to ask questions before giving their consent to any procedure. Patients may need to book a double or triple appointment depending on the treatment chosen."

Mihi Blair, Kaiwhakahaere Hauora Māori (General Manager - Māori Health and Equity) at ProCare believes these changes will mean the support provided to patients can be done more equitably.

“For Māori, Pacific peoples, and those living in rural areas, easier access to essential treatments can make a real difference to their health. It’s encouraging to see Pharmac responding to the needs of our communities.”

ProCare supports aligning medicine access with clinical guidelines and responding to how we can improve patient experience. The changes will help streamline care delivery, reduce administrative burden, and empower clinicians to provide timely, effective treatment.

“We look forward to working with our practices to implement these changes smoothly and ensure patients are informed and supported,” says Norwell.